Titlebook: Evidence-Based Psoriasis; Diagnosis and Treatm Tina Bhutani,Wilson Liao,Mio Nakamura Book 2018 Springer International Publishing AG, part o

Fibroid

alcoholism

吝嗇性

Updates in Clinical Dermatologyhttp://image.papertrans.cn/e/image/317574.jpg

labile

Chronological

Graves’-disease

https://doi.org/10.1007/978-3-662-11675-3Currently, ultraviolet (UV)-based therapy is one of the first-line therapies for psoriasis due to its high response rate, relative low cost, and minimal generalized immunosuppression compared to other systemic therapies. This chapter will outline the basic principles of photomedicine and photochemis

酷熱

Energie-Effizienzbewertung von Geb?udened to treat psoriasis include cytotoxic and immunomodulatory drugs such as methotrexate, cyclosporine, and apremilast. Another oral agent, acitretin, is a systemic retinoid that affects epidermal proliferation and differentiation as well as immunomodulation. Oral agents for psoriasis are effective a

OVERT

官僚統(tǒng)治

Milton Burton,Günther O. Schenckcements have transformed treatment regimens for psoriasis by selectively targeting immune signaling molecules. The aim of this chapter is to review the clinical and research data surrounding these emerging treatments, ranging from those undergoing development to those already in clinical trials. The

竊喜

Alexander Nikuradse,Hans J. Maderseverity of psoriasis. Using two or more therapies with varying mechanisms of action and safety profiles is often necessary to maintain adequate disease control while minimizing toxicity of treatments. Choosing a combination regimen that maximizes safety and efficacy, while at the same time consider